Tag: opzelura

All

FDA Extends Review of Opzelura for Pediatric Atopic Dermatitis

Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.

All

Sorry, No Posts Found

All

Patient Perspective as Clinical Data: Dr Steven Dayan on PROs and Aesthetic Outcomes

Dr Steven Dayan discusses how patient-reported outcomes (PROs) are shaping clinical research, regulatory standards, and patient care in aesthetic medicine.

Cold Ablative Fiber Laser Gains Regulatory Approval in Canada
AAD Issues Strong Recommendations for Four Therapies in Updated Atopic Dermatitis Guidelines
The Aesthetic Society Updates Its Educational Platform with Netflix-Style Interface

Tag: opzelura

All

FDA Extends Review of Opzelura for Pediatric Atopic Dermatitis

All

Sorry, No Posts Found

All

Patient Perspective as Clinical Data: Dr Steven Dayan on PROs and Aesthetic Outcomes

Cold Ablative Fiber Laser Gains Regulatory Approval in Canada

AAD Issues Strong Recommendations for Four Therapies in Updated Atopic Dermatitis Guidelines

The Aesthetic Society Updates Its Educational Platform with Netflix-Style Interface

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links